Infectious Diseases News and Research

RSS

Researchers discover new way to disarm harmful bacteria

Rather than trying to kill bacteria outright with drugs, Université de Montréal researchers have discovered a way to disarm bacteria that may allow the body's own defense mechanisms to destroy them. "To understand this strategy one could imagine harmful bacteria being like Darth Vader, and the anti-virulence drug would take away his armor and lightsaber," explained Dr. Christian Baron, the study's lead author and Professor at the Department of Biochemistry.

24 Aug 2012

New disease causes AIDS-like symptoms but not spread through virus

"Researchers have identified a mysterious new disease that has left scores of people in Asia and some in the United States with AIDS-like symptoms even though they are not infected with HIV," the Associated Press reports.

24 Aug 2012

The Wistar Institute, MSKCC partner to publish first annotated atlas of Epstein-Barr virus genome

Researchers from The Wistar Institute and Memorial Sloan-Kettering Cancer Center (MSKCC) have teamed to publish the first annotated atlas of the Epstein-Barr virus genome, creating the most comprehensive study of how the viral genome interacts with its human host during a latent infection. Epstein-Barr virus (EBV), which is thought to be responsible for one percent of all human cancers, establishes a latent infection in nearly 100 percent of infected adult humans.

24 Aug 2012

Scripps Research Institute scientist to uncover workings of the immune system

A team led by a scientist at The Scripps Research Institute has received a $22.5 million, five-year project renewal from the National Institutes of Health to uncover the workings of the immune system.

24 Aug 2012

OUP, prestigious Royal Society of Tropical Medicine and Hygiene journals announce partnership

The Royal Society of Tropical Medicine and Hygiene's two prestigious journals will join the Oxford University Press (OUP) collection in a new partnership announced between the organizations.

24 Aug 2012

Concern over ameba-infested tap water deaths

People with sinusitis who regularly treat their condition using nasal irrigation should be aware of a potential contamination risk associated with using inadequately filtered tap water, say US researchers.

23 Aug 2012

National Institute of Allergy and Infectious Diseases announces HIV vaccine initiative awards

"Researchers at 14 institutions will explore new approaches to designing a vaccine against HIV with awards that are part of an anticipated four-year, $34.8 million initiative, the National Institute of Allergy and Infectious Diseases [NIAID] announced Tuesday," the Center for Global Health Policy's "Science Speaks" blog reports.

23 Aug 2012

New results describe development of DC cancer vaccine with enhanced immunogenic potential

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at Radboud University Nijmegen Medical Centre in the Netherlands announced today that they have published new pre-clinical results in the journal Cancer Immunology Immunotherapy describing the development of a dendritic cell (DC) cancer vaccine with enhanced immunogenic potential.

23 Aug 2012

Aeras, IDRI announce start of first ID93 + GLA-SE Phase I trial for tuberculosis

Aeras and the Infectious Disease Research Institute (IDRI) announce today the start of the first clinical trial of IDRI's novel tuberculosis vaccine candidate, ID93 + GLA-SE.

23 Aug 2012

HIV-related stigma keeps Kenyan pregnant women from having babies in health-care facilities

The fear of being labeled HIV-positive is strong enough to keep mothers in one Kenyan province from having babies in health-care facilities, according to a study published online today in the journal PLOS Medicine. Communities there have come to see clinics and skilled care as mostly for HIV-positive women.

22 Aug 2012

NIAID announces 14 grants for basic research to identify new HIV vaccine approaches

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded 14 grants totaling $7.8 million in first-year funding for basic research to identify new approaches for designing a safe and effective HIV vaccine.

22 Aug 2012

Highly sensitive troponin assay shortens heart attack diagnosis

An algorithm that incorporates high-sensitivity cardiac troponin could allow accurate rule-in and rule-out of patients with acute chest pain within 1 hour of presentation, a study shows.

21 Aug 2012

Genetic key to severe malaria resistance uncovered

Researchers have identified two genetic variants linked with human resistance to severe malaria.

21 Aug 2012

International guidelines improve outcomes after dental trauma

Adhering to the current International Association of Dental Traumatology guidelines for emergency treatment and care of traumatized teeth results in significantly lower complication rates, report researchers in Clinical Oral Investigations.

21 Aug 2012

CHD patients do not need to rule out high-intensity exercise

Findings from a retrospective study show that patients with coronary heart disease who engage in high-intensity exercise have a similarly low risk for a cardiovascular event as those engaging in moderate-intensity exercise.

21 Aug 2012

Declining circumcision rates in the US raise healthcare costs and disease risk

A team of disease experts and health economists at Johns Hopkins warns that steadily declining rates of U.S. infant male circumcision could add more than $4.4 billion in avoidable health care costs if rates over the next decade drop to levels now seen in Europe.

21 Aug 2012

Declining rates of circumcision in US infant males could add billions to health care costs

21 Aug 2012

Medivir initiates MIV-711 phase Ib trial in healthy volunteers

Medivir AB, the research-based pharmaceutical company focused on the development of high-value treatments for infectious diseases, is reporting today that a clinical phase Ib trial of the company's candidate drug (CD) MIV-711 has commenced.

21 Aug 2012

BioDiem and French partner VIVALIS a step forward in developing vaccines for diseases and related cancers

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) announced today successful results from two programs of work carried out by French partner VIVALIS (NYSE Euronext: VLS), confirming the ability of BioDiem’s Live Attenuated Influenza Virus (LAIV) to grow in VIVALIS’ proprietary EB66® cell line.

20 Aug 2012

Talk smoothes the way to better understanding sick babies

Clinicians must foster improved communication with the mothers of critically ill newborns to improve understanding of their child’s condition, research suggests.

20 Aug 2012

Infectious Diseases News and Research

Researchers discover new way to disarm harmful bacteria

New disease causes AIDS-like symptoms but not spread through virus

The Wistar Institute, MSKCC partner to publish first annotated atlas of Epstein-Barr virus genome

Scripps Research Institute scientist to uncover workings of the immune system

OUP, prestigious Royal Society of Tropical Medicine and Hygiene journals announce partnership

Concern over ameba-infested tap water deaths

National Institute of Allergy and Infectious Diseases announces HIV vaccine initiative awards

New results describe development of DC cancer vaccine with enhanced immunogenic potential

Aeras, IDRI announce start of first ID93 + GLA-SE Phase I trial for tuberculosis

HIV-related stigma keeps Kenyan pregnant women from having babies in health-care facilities

NIAID announces 14 grants for basic research to identify new HIV vaccine approaches

Highly sensitive troponin assay shortens heart attack diagnosis

Genetic key to severe malaria resistance uncovered

International guidelines improve outcomes after dental trauma

CHD patients do not need to rule out high-intensity exercise

Declining circumcision rates in the US raise healthcare costs and disease risk

Declining rates of circumcision in US infant males could add billions to health care costs

Medivir initiates MIV-711 phase Ib trial in healthy volunteers

BioDiem and French partner VIVALIS a step forward in developing vaccines for diseases and related cancers

Talk smoothes the way to better understanding sick babies

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News